Hyperglycaemia management in non-critical care settings: guidelines in focus

Abstract

The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting and longer-acting insulins; the increasing use of continuous glucose monitoring (CGM) for patients on insulin; the development of more automated insulin pumps; and much new information on the management of hospital inpatients.